In the FY 2021 IPPS/LTCH PPS final rule (85 FR 58448), we finalized our proposal to expand our existing criteria to create a new complication or comorbidity (CC) or major complication or comorbidity (MCC) subgroup within a base MS-DRG
Detoxification Support: Assists the liver in detoxifying harmful substances, promoting better bodily function
IV Drip Therapy supports the immune system by restoring and boosting the bodys natural defenses, aiding recovery and building resilience
This process contributes to cellular redox balance, energy production and sulfide homeostasis, particularly in tissues with high metabolic activity such as the brain, liver and heart 48,49,50,51
This understanding affects everything from packaging presentation to treatment protocols and retail pricing strategy